UA
33
3
CMA
45
-4
CHRW
44
7
SPG
55
5
DG
24
-4
GIS
60
2
IFF
47
5
URI
76
8
PNR
65
3
UNP
53
-2
TAP
48
4
IP
36
6
ADT
19
2
EXR
40
9
VLO
35
5
TXT
68
3
ICE
53
-2
STT
50
3
VZ
29
2
PXD
50
4
UA
33
3
CMA
45
-4
CHRW
44
7
SPG
55
5
DG
24
-4
GIS
60
2
IFF
47
5
URI
76
8
PNR
65
3
UNP
53
-2
TAP
48
4
IP
36
6
ADT
19
2
EXR
40
9
VLO
35
5
TXT
68
3
ICE
53
-2
STT
50
3
VZ
29
2
PXD
50
4
Financhill
Back

Amedisys Quote, Financials, Valuation and Earnings

Election Shock on August 19th?

Click here now to see the evidence I've gathered.
Buy
54

AMED
Amedisys

Last Price:
91.51
Seasonality Move:
7.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon's Secret "A.I. 2.0" Project

Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project

Amedisys Price Quote

$91.51
-0.33 (-0.36%)
(Updated: April 30, 2024 at 10:00 AM ET)

Amedisys Key Stats

Buy
54
Amedisys (AMED) is a Buy
Day range:
$91.75 - $92.52
52-week range:
$73.10 - $96.44
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.34
P/B ratio:
2.76%
Volume:
232.5K
Avg. volume:
248.2K
1-year change:
14.37%
Market cap:
$3B
Revenue:
$2.2B
EPS:
$-0.64

How Much Does Amedisys Make?

  • How Much Are Amedisys's Sales Annually?
    AMED Revenues are $2.2B
  • How Much Profit Does Amedisys's Make A Year?
    AMED net income is -$9.7M

Is Amedisys Growing As A Company?

  • What Is Amedisys's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.03%
  • What Is Amedisys's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.43%

Amedisys Stock Price Performance

  • Did Amedisys Stock Go Up Last Month?
    Amedisys share price went down by -0.35% last month
  • Did AMED's Share Price Rise Over The Last Year?
    AMED share price rose by 14.37% over the past 1 year

What Is Amedisys 52-Week High & Low?

  • What Is Amedisys’s 52-Week High Share Price?
    Amedisys has traded as high as $96.44 over the past 52 weeks
  • What Is Amedisys’s 52-Week Low Share Price?
    Amedisys has traded as low as $73.10 over the past 52 weeks

Amedisys Price To Free Cash Flow

  • Is Amedisys Stock Overvalued?
    Amedisys is trading at a price to free cash flow ratio of 33.19
  • Is Amedisys Stock Undervalued?
    Amedisys EV to Free Cash Flow ratio is 36.86
  • What Is Amedisys’s Price Earnings Growth Ratio?
    AMED PEG ratio is 0.00
  • Is Amedisys Trading At A Premium To Earnings?
    Amedisys EV to EBIT ratio is 52.18

Is It Risky To Buy Amedisys?

  • How Much Debt Does Amedisys Have?
    Total long term debt quarterly is $393.3M
  • How Much Cash Does Amedisys Have?
    Cash and short term investments quarterly total is $108.2M
  • What Is Amedisys’s Book Value Per Share?
    Book value per share is 33.30

Is Amedisys Cash Flow Positive?

  • What Is AMED Cash Flow From Operations?
    Cash flow from operations (TTM) is $104.7M
  • What Is Amedisys’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$39.2M
  • What Is Amedisys’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$13.9M

Amedisys Return On Invested Capital

  • Is Management Doing A Good Job?
    AMED return on invested capital is -1.37%
  • What Is Amedisys Return On Assets?
    ROA measures how assets are converting to revenues and is -1.02%
  • What Is AMED Return On Equity?
    ROE is a measure of profitability and is -1.86%

Amedisys Earnings Date & Stock Price

  • What Is Amedisys's Stock Price Today?
    A single share of AMED can be purchased today for 91.84
  • What Is Amedisys’s Stock Symbol?
    Amedisys trades on the nasdaq under the ticker symbol: AMED
  • When Is Amedisys’s Next Earnings Date?
    The next quarterly earnings date for Amedisys is scheduled on May 3, 2024
  • When Is AMED's next ex-dividend date?
    Amedisys's next ex-dividend date is April 30, 2024
  • How To Buy Amedisys Stock?
    You can buy Amedisys shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Amedisys Competitors

  • Who Are Amedisys's Competitors?
    Below is a list of companies who compete with Amedisys or are related in some way:
    • Addus HomeCare Corp (ADUS)
    • Chemed Corp (CHE)
    • Option Care Health Inc (OPCH)
    • OptimizeRx Corp (OPRX)
    • Regional Health Properties Inc (RHE)

Amedisys Dividend Yield

Data Unavailable

Amedisys Analyst Estimates

YoY Growth Past Surprise
EPS: -42.86% 2.03%
Revenue: 2.7% 0.38%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 6
Sell Recommendations: 1
Price Target: 97.78
Upside from Last Price: 6.47%

Major Shareholders

  • How many AMED shares are owned by institutional investors?
    43.2M AMED shares are owned by institutional investors
  • How many AMED shares are owned by insiders?
    3.3M AMED shares are owned by insiders